(€'000) 2018 2019 Variation

   

 

- Depreciation of property, plant and equipment
- Depreciation of right-of-use assets

- Amortisation of contract costs 21,987 25,232

 

- Amortisation of intangible assets 922 593 (329)

Amortisation and depreciation 156,049 170,936 14,887
Provisions (5,398) 1,001 6,399

 

 

Total amortisation, depreciation and provisions 150,651 171,937 21,286

 

Total 345,170 274,360 (70,810)

Impairment losses of €102.4 million mainly relate to:

- the impairment losses of €45.8 million related to receivables due to COCIV from the consortium

member Condotte given that it is currently under extraordinary administration;

- the impairment losses on assets in Venezuela (€35.7 million) as a result of the impairment test
performed at the reporting date (reference should be made to the “Venezuela” paragraph of the “Main
risk factors and uncertainties” section of the Directors’ report and the paragraph on “Impairment -
Venezuela” in note 16). The impairment losses recognised on the Venezuelan contracts amounted to

€165.5 million in 2018.

The item also includes the impairment losses recognised on trade receivables for the road contracts in Poland
(€6.8 million), the USW projects in Campania following the Naples Court's first level hearing (€4.7 million) and
the Al Bayt Stadium in Qatar (€4.0 million).

On 1 January 2019, the Group adopted IFRS 16 which introduced new guidelines for the accounting treatment
of leased assets and their depreciation. As a result, it introduced a new item “Depreciation of right-of-use assets”.

In 2018, depreciation of leased assets was included under depreciation of property, plant and equipment.

36. Net financing costs

Net financing costs amount to €73.2 million compared to €72.9 million for 2018.

The item may be broken down as follows:

 

349
